Prostate-Specific Antigen (PSA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064463
  • May 2021
  • Biotechnology
  • 142 Pages
The Prostate-Specific Antigen (PSA) Testing Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Inc., AstraZeneca plc., Bayer AG, Beckman Coulter, Inc., Bristol - Myers Squibb Company, GE Healthcare, GlaxoSmithKline, plc, Merck & Co., Inc., Novartis Pharma AG, UroLogix, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Prostate-Specific Antigen (PSA) Testing market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Prostate-Specific Antigen (PSA) Testing market is expected to attain Pre COVID-19 levels by mid-2022.

Prostate-Specific Antigen (PSA) Testing Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Prostate-Specific Antigen (PSA) Testing market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Prostate-Specific Antigen (PSA) Testing Market Competitive and Premeditated Analysis
In the Prostate-Specific Antigen (PSA) Testing report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Prostate-Specific Antigen (PSA) Testing research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Prostate-Specific Antigen (PSA) Testing Market:
The Prostate-Specific Antigen (PSA) Testing market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Inc., AstraZeneca plc., Bayer AG, Beckman Coulter, Inc., Bristol - Myers Squibb Company, GE Healthcare, GlaxoSmithKline, plc, Merck & Co., Inc., Novartis Pharma AG, UroLogix, Inc.

The Prostate-Specific Antigen (PSA) Testing market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Prostate-Specific Antigen (PSA) Testing Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Prostate-Specific Antigen (PSA) Testing market:
by Tests type
Total Prostate Specific Antigen Test
tPSA
Complex Prostate Specific Antigen Test
cPSA
Free Prostate Specific Antigen Test
fPSA
Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
PSA RT-PCR
PCA3Test
Trans-rectal Ultrasound
Biopsy
Assays type
Radioimmunoassay
RIA
Enzyme Immunoassay
EIA

Regional Analysis of the Prostate-Specific Antigen (PSA) Testing market:
The Prostate-Specific Antigen (PSA) Testing market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Prostate-Specific Antigen (PSA) Testing report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Prostate-Specific Antigen (PSA) Testing market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Prostate-Specific Antigen (PSA) Testing market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Prostate-Specific Antigen (PSA) Testing market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Prostate-Specific Antigen (PSA) Testing market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Prostate-Specific Antigen (PSA) Testing market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Prostate-Specific Antigen (PSA) Testing market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Prostate-Specific Antigen (PSA) Testing market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Prostate-Specific Antigen (PSA) Testing market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories, Inc.
  • AstraZeneca plc.
  • Bayer AG
  • Beckman Coulter, Inc.
  • Bristol - Myers Squibb Company
  • GE Healthcare
  • GlaxoSmithKline, plc
  • Merck & Co., Inc.
  • Novartis Pharma AG
  • UroLogix, Inc.
  • Total Prostate Specific Antigen Test
  • tPSA
  • Radioimmunoassay
  • RIA
  • Enzyme Immunoassay
  • EIA

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Prostate-Specific Antigen (PSA) Testing Market Snapshot
          2.1.1. Global Prostate-Specific Antigen (PSA) Testing Market By Tests type,2019
               2.1.1.1.Total Prostate Specific Antigen Test
               2.1.1.2.tPSA
          2.1.2. Global Prostate-Specific Antigen (PSA) Testing Market By Assays type,2019
               2.1.2.1.Radioimmunoassay
               2.1.2.2.RIA
               2.1.2.3.Enzyme Immunoassay
               2.1.2.4.EIA
          2.1.3. Global Prostate-Specific Antigen (PSA) Testing Market By End-use,2019
          2.1.4. Global Prostate-Specific Antigen (PSA) Testing Market By Geography,2019

3. Global Prostate-Specific Antigen (PSA) Testing Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Tests type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Tests type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Tests type, 2020
     4.2. Global Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Tests type, 2018 – 2028

5. Global Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Assays type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Assays type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Assays type, 2020
     5.2. Global Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Assays type, 2018 – 2028

6. Global Prostate-Specific Antigen (PSA) Testing Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Prostate-Specific Antigen (PSA) Testing Market Size (US$), By End-use, 2018 – 2028

7. Global Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Prostate-Specific Antigen (PSA) Testing Market Analysis, 2018 – 2028 
          7.2.1. North America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Tests type, 2018 – 2028
          7.2.3. North America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Assays type, 2018 – 2028
          7.2.4. North America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Prostate-Specific Antigen (PSA) Testing Market Analysis, 2018 – 2028 
          7.3.1.  Europe Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Tests type, 2018 – 2028
          7.3.3. Europe Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Assays type, 2018 – 2028
          7.3.4. Europe Prostate-Specific Antigen (PSA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Tests type, 2018 – 2028
          7.4.3. Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Assays type, 2018 – 2028
          7.4.4. Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Prostate-Specific Antigen (PSA) Testing Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Tests type, 2018 – 2028
          7.5.3. Latin America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Assays type, 2018 – 2028
          7.5.4. Latin America Prostate-Specific Antigen (PSA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Prostate-Specific Antigen (PSA) Testing Market Analysis, 2018 – 2028 
          7.6.1.  MEA Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Tests type, 2018 – 2028
          7.6.3. MEA Prostate-Specific Antigen (PSA) Testing Market Size (US$), By Assays type, 2018 – 2028
          7.6.4. MEA Prostate-Specific Antigen (PSA) Testing Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Prostate-Specific Antigen (PSA) Testing Providers
        8.4.1 Abbott Laboratories, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories, Inc. Geographic Operations
                8.4.1.3 Abbott Laboratories, Inc. Financial Information
                8.4.1.4 Abbott Laboratories, Inc. Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories, Inc. Key Developments
        8.4.2 AstraZeneca plc.
                8.4.2.1 Business Description
                8.4.2.2 AstraZeneca plc. Geographic Operations
                8.4.2.3 AstraZeneca plc. Financial Information
                8.4.2.4 AstraZeneca plc. Product Positions/Portfolio
                8.4.2.5 AstraZeneca plc. Key Developments
        8.4.3 Bayer AG
                8.4.3.1 Business Description
                8.4.3.2 Bayer AG Geographic Operations
                8.4.3.3 Bayer AG Financial Information
                8.4.3.4 Bayer AG Product Positions/Portfolio
                8.4.3.5 Bayer AG Key Developments
        8.4.4 Beckman Coulter, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Beckman Coulter, Inc. Geographic Operations
                8.4.4.3 Beckman Coulter, Inc. Financial Information
                8.4.4.4 Beckman Coulter, Inc. Product Positions/Portfolio
                8.4.4.5 Beckman Coulter, Inc. Key Developments
        8.4.5 Bristol - Myers Squibb Company
                8.4.5.1 Business Description
                8.4.5.2 Bristol - Myers Squibb Company Geographic Operations
                8.4.5.3 Bristol - Myers Squibb Company Financial Information
                8.4.5.4 Bristol - Myers Squibb Company Product Positions/Portfolio
                8.4.5.5 Bristol - Myers Squibb Company Key Developments
        8.4.6 GE Healthcare
                8.4.6.1 Business Description
                8.4.6.2 GE Healthcare Geographic Operations
                8.4.6.3 GE Healthcare Financial Information
                8.4.6.4 GE Healthcare Product Positions/Portfolio
                8.4.6.5 GE Healthcare Key Developments
        8.4.7 GlaxoSmithKline, plc
                8.4.7.1 Business Description
                8.4.7.2 GlaxoSmithKline, plc Geographic Operations
                8.4.7.3 GlaxoSmithKline, plc Financial Information
                8.4.7.4 GlaxoSmithKline, plc Product Positions/Portfolio
                8.4.7.5 GlaxoSmithKline, plc Key Developments
        8.4.8 Merck & Co., Inc.
                8.4.8.1 Business Description
                8.4.8.2 Merck & Co., Inc. Geographic Operations
                8.4.8.3 Merck & Co., Inc. Financial Information
                8.4.8.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.8.5 Merck & Co., Inc. Key Developments
        8.4.9 Novartis Pharma AG
                8.4.9.1 Business Description
                8.4.9.2 Novartis Pharma AG Geographic Operations
                8.4.9.3 Novartis Pharma AG Financial Information
                8.4.9.4 Novartis Pharma AG Product Positions/Portfolio
                8.4.9.5 Novartis Pharma AG Key Developments
        8.4.10 UroLogix, Inc.
                8.4.10.1 Business Description
                8.4.10.2 UroLogix, Inc. Geographic Operations
                8.4.10.3 UroLogix, Inc. Financial Information
                8.4.10.4 UroLogix, Inc. Product Positions/Portfolio
                8.4.10.5 UroLogix, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Prostate-Specific Antigen (PSA) Testing Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Prostate-Specific Antigen (PSA) Testing Market Revenue, By Tests type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Prostate-Specific Antigen (PSA) Testing Market Revenue, By Assays type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Prostate-Specific Antigen (PSA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Prostate-Specific Antigen (PSA) Testing Market Revenue, By Tests type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Prostate-Specific Antigen (PSA) Testing Market Revenue, By Assays type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Prostate-Specific Antigen (PSA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Revenue, By Tests type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Revenue, By Assays type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Prostate-Specific Antigen (PSA) Testing Market Revenue, By Tests type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Prostate-Specific Antigen (PSA) Testing Market Revenue, By Assays type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Prostate-Specific Antigen (PSA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Prostate-Specific Antigen (PSA) Testing Market Revenue, By Tests type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Prostate-Specific Antigen (PSA) Testing Market Revenue, By Assays type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Prostate-Specific Antigen (PSA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Prostate-Specific Antigen (PSA) Testing: Market Segmentation 
FIG. 2 Global Prostate-Specific Antigen (PSA) Testing Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Prostate-Specific Antigen (PSA) Testing Market, By Tests type, 2019 (US$ Mn) 
FIG. 5 Global Prostate-Specific Antigen (PSA) Testing Market, By Assays type, 2019 (US$ Mn) 
FIG. 6 Global Prostate-Specific Antigen (PSA) Testing Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Prostate-Specific Antigen (PSA) Testing Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Prostate-Specific Antigen (PSA) Testing Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Prostate-Specific Antigen (PSA) Testing Providers, 2019
FIG. 11 Global Prostate-Specific Antigen (PSA) Testing Market Revenue Contribution, By Tests type, 2019 & 2028 (Value %) 
FIG. 12 Global Prostate-Specific Antigen (PSA) Testing Market Revenue Contribution, By Assays type, 2019 & 2028 (Value %) 
FIG. 13 Global Prostate-Specific Antigen (PSA) Testing Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Prostate-Specific Antigen (PSA) Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Prostate-Specific Antigen (PSA) Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Prostate-Specific Antigen (PSA) Testing Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Prostate-Specific Antigen (PSA) Testing Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Prostate-Specific Antigen (PSA) Testing market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Prostate-Specific Antigen (PSA) Testing Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Prostate-Specific Antigen (PSA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  North America Prostate-Specific Antigen (PSA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  North America Prostate-Specific Antigen (PSA) Testing Market Value, By Country, 2018 – 2028
TABLE  Europe Prostate-Specific Antigen (PSA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  Europe Prostate-Specific Antigen (PSA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  Europe Prostate-Specific Antigen (PSA) Testing Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Value, By Country, 2018 – 2028
TABLE  Latin America Prostate-Specific Antigen (PSA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Prostate-Specific Antigen (PSA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Prostate-Specific Antigen (PSA) Testing Market Value, By Country, 2018 – 2028
TABLE  MEA Prostate-Specific Antigen (PSA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  MEA Prostate-Specific Antigen (PSA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  MEA Prostate-Specific Antigen (PSA) Testing Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Beckman Coulter, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol - Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GE Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline, plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis Pharma AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  UroLogix, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Prostate-Specific Antigen (PSA) Testing Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Prostate-Specific Antigen (PSA) Testing Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Prostate-Specific Antigen (PSA) Testing Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Prostate-Specific Antigen (PSA) Testing Market, By Geography, 2019 (US$ Mn)
FIG.  Global Prostate-Specific Antigen (PSA) Testing Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Prostate-Specific Antigen (PSA) Testing Providers, 2016
FIG.  Global Prostate-Specific Antigen (PSA) Testing Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global tPSA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Prostate-Specific Antigen (PSA) Testing Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global RIA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Enzyme Immunoassay Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global EIA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Prostate-Specific Antigen (PSA) Testing Market Value, 2018 – 2028, (US$ Mn)